Belgium's Ablynx triples cooperation deal with Merck & Co
July 22, 2015 at 01:49 AM EDT
BRUSSELS, July 22 (Reuters) - Belgian biotech group Ablynx on Wednesday said it had tripled its research deal with U.S. drugmaker Merck & Co leading to potential milestone payments of about 4 billion euros ($4.38 billion).
